**Core Concept**
The patient's symptoms, including ocular examination findings and Achilles tendon nodules, are suggestive of a systemic condition known as **Sarcoidosis**. This multi-systemic disease is characterized by the formation of non-caseating granulomas, which can affect various organs, including the eyes and skin. The disease is thought to result from an abnormal immune response, with an imbalance between pro-inflammatory and anti-inflammatory cytokines.

**Why the Correct Answer is Right**
The patient's symptoms are consistent with a diagnosis of Sarcoidosis, which is known to be associated with an overproduction of **Inflammatory Cytokines**, including TNF-alpha and IL-12. However, the correct answer lies in the fact that the therapy for Sarcoidosis should focus on increasing the levels of a specific gene product in hepatocyte cell membranes. This product is crucial for the proper functioning of the immune system and has been shown to have anti-inflammatory properties.

**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect, as increasing the levels of **IL-1 Beta** would actually exacerbate inflammation and worsen the symptoms of Sarcoidosis.

**Option B:** Incorrect, as **IL-6** is a cytokine involved in the regulation of acute phase response, but increasing its levels would not be beneficial in the treatment of Sarcoidosis.

**Option C:** Incorrect, as **IL-2** is a cytokine involved in the activation of T-cells, but increasing its levels would not be the primary goal in the treatment of Sarcoidosis.

**Option D:** Incorrect, as **IL-10** is an anti-inflammatory cytokine, but the correct answer is not about increasing the levels of an anti-inflammatory cytokine, but rather a specific gene product involved in the immune response.

**Clinical Pearl / High-Yield Fact**
In patients with Sarcoidosis, it is essential to differentiate between the symptoms of the disease and the side effects of the therapy. Corticosteroids are often used to manage the symptoms, but their long-term use can lead to various side effects, including osteoporosis, glaucoma, and cataracts.

**Correct Answer:** D.
IL-1 Receptor Antagonist (Anakinra)